FDA Approval Summary: Atezolizumab plus paclitaxel protein-bound for the treatment of patients with advanced or metastatic TNBC whose tumors express PD-L1
| Image |  |
|---|---|
| Description | scientific article published on 30 January 2020 |
| Author/s |
author: Kirsten B Goldberg Jennifer J Gao |
| Publication date | January 30, 2020 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |